Inuver (Beclometasone Dipropionate, Formoterol Fumarate Dihydrate)

Beclometasone dipropionate acts as a glucocorticoid, suppressing airway inflammation by modulating gene expression. Formoterol is a long‑acting β2‑adrenergic agonist that relaxes bronchial smooth muscle, providing sustained bronchodilation. Together they address both inflammation and airway constriction.

The specific dose and frequency of Inuver are determined by the prescribing healthcare professional based on the patient’s age, disease severity, and response to therapy. Patients should follow the exact instructions provided on the prescription label.

Safety data for Inuver in pregnancy and lactation are limited. The decision to use it should be made by a qualified clinician after weighing potential benefits against possible risks to the mother and infant.

To request Inuver, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Inuver combines an inhaled corticosteroid with a long‑acting β2‑agonist in a single device, offering convenience over separate inhalers. Compared with monotherapy options, it provides both anti‑inflammatory and bronchodilator effects, which can improve adherence and overall disease control in many patients.

Store Inuver at room temperature, below 25 °C, in its original packaging. Keep the inhaler away from moisture, direct sunlight and heat sources to maintain product stability and aerosol performance.

Inuver is delivered via an inhalation aerosol. The patient inhales the prescribed number of puffs through the mouthpiece, preferably using a spacer device, and then rinses the mouth to reduce local side effects. Detailed technique instructions are provided by the prescriber.

Serious risks include paradoxical bronchospasm, adrenal suppression from the corticosteroid component, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience sudden breathing difficulty, swelling, or rash after using the inhaler.

Inuver is contraindicated in individuals with a known hypersensitivity to beclometasone, formoterol, or any excipients in the formulation. Caution is also advised for patients with uncontrolled cardiovascular disease, severe arrhythmias, or those taking non‑selective β‑blockers.